{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:21Z","timestamp":1791357201847,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.schres.2011.06.016","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T21:24:35Z","timestamp":1311542675000},"page":"28-34","source":"Crossref","is-referenced-by-count":14,"title":["Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone"],"prefix":"10.1016","volume":"132","author":[{"given":"Jennifer Kern","family":"Sliwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Bossie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Alphs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2011.06.016_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.schres.2011.06.016_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.016_bb0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5414\/CPP47606","article-title":"The influence of hepatic impairment on the pharmacokinetics of paliperidone","volume":"47","author":"Boom","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2011.06.016_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.06.016_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/YIC.0b013e3282fce651","article-title":"Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone","volume":"23","author":"Canuso","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2011.06.016_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/YIC.0b013e3283372977","article-title":"Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone","volume":"25","author":"Canuso","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2011.06.016_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1742-1241.2009.02240.x","article-title":"Paliperidone palmitate: review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication","volume":"64","author":"Citrome","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.schres.2011.06.016_bb0040","first-page":"18","article-title":"Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics","volume":"64","author":"Ereshefsky","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.016_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1185\/03007990903482772","article-title":"Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia","volume":"26","author":"Gopal","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2011.06.016_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/YIC.0b013e32833948fa","article-title":"Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose\u2013response study","volume":"25","author":"Gopal","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2011.06.016_bb0055","first-page":"218","article-title":"ECDEU Assessment Manual for Psychopharmacology (028 Clinical Global Impressions [CGI])","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2011.06.016_bb0060","first-page":"534","article-title":"ECDEU Assessment Manual for Psychopharmacology, revised 1976 (Abnormal Involuntary Movement Scale [AIMS])","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2011.06.016_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2009.10.026","article-title":"Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"116","author":"Hough","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2011.06.016_bb0070","series-title":"(paliperidone palmitate) extended-release injectable suspension","author":"Invega\u00ae Sustenna\u00ae","year":"2010"},{"key":"10.1016\/j.schres.2011.06.016_bb0075","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1192\/bjp.195.52.s63","article-title":"Clinical guideline recommendations for antipsychotic long-acting injections","volume":"195","author":"Kane","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.016_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2011.06.016_bb0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S1461145709990988","article-title":"Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study","volume":"13","author":"Kramer","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2011.06.016_bb0090","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2011.06.016_bb0095","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4088\/JCP.08m04221","article-title":"Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response","volume":"70","author":"Lindenmayer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.016_bb0100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4088\/JCP.v58n1205","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials","volume":"58","author":"Marder","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"suppl 5","key":"10.1016\/j.schres.2011.06.016_bb0105","first-page":"15","article-title":"Risks versus benefits of different types of long-acting injectable antipsychotics","volume":"67","author":"McEvoy","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.016_bb0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2000.tb10933.x","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2011.06.016_bb0115","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0447.2006.00982.x","article-title":"The case for long-acting antipsychotic agents in the post-CATIE era","volume":"115","author":"Nasrallah","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2011.06.016_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psychres.2009.05.004","article-title":"Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia","volume":"176","author":"Novick","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2011.06.016_bb0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/JCP.0b013e3181dd3103","article-title":"A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia","volume":"30","author":"Pandina","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2011.06.016_bb0130","series-title":"(risperidone) tablets\/oral solution","author":"Risperdal\u00ae","year":"2010"},{"key":"10.1016\/j.schres.2011.06.016_bb0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11316870-000000000-00000","article-title":"Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia: a novel once-monthly, long-acting formulation of an atypical antipsychotic","volume":"48","author":"Samtani","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.schres.2011.06.016_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2011.06.016_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.7090su1cj","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.06.016_bb0150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1124\/dmd.107.018275","article-title":"Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans","volume":"36","author":"Vermeir","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.schres.2011.06.016_bb0155","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/appi.ps.55.8.886","article-title":"Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia","volume":"55","author":"Weiden","year":"2004","journal-title":"Psychiatr. Serv."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411003215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411003215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T17:11:29Z","timestamp":1638119489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411003215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0920996411003215"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.06.016","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}